Clovis Oncology, Inc. Skyrocketed

Fri, Jul 01, 2022 at 07:35 PM
Clovis Oncology, Inc. Skyrocketed

Clovis Oncology, Inc. (CLVS:NASDAQ) jumped higher at $2.85, representing a gain of 58.3%. On Fri, Jul 01, 2022, CLVS:NASDAQ touched a New 2-Week High of $2.85. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Fri, Jun 17, 2022, the stock recorded 55.56% Up Days and 80.00% Green Days

About Clovis Oncology, Inc. (CLVS:NASDAQ)

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.